AbbVie Inc. Investing Cash Flow 2011-2026 | ABBV
Beta
What is investing cash flow?
Investing cash flow represents cash used for or generated from investment activities, including capital expenditures, acquisitions, and investment purchases or sales.
What is AbbVie Inc.'s current investing cash flow?
AbbVie Inc. (ABBV) annual investing cash flow for 2025 was $-6.64B, a 68.09% increase from 2024. AbbVie Inc. investing cash flow for the quarter ending March 31, 2026 was $-574.0M.
What was AbbVie Inc.'s investing cash flow in 2024?
AbbVie Inc. annual investing cash flow for 2024 was $-20.82B, a 936.34% decline from 2023.
What was AbbVie Inc.'s investing cash flow in 2023?
AbbVie Inc. annual investing cash flow for 2023 was $-2.01B, a 222.47% decline from 2022.
Investing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-37.56B
→
FY2025
$-6.64B
111213141516171819202122232425
5 years selected
Investing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-6.64B | +68.1% | 10-K |
| FY2024 | $-20.82B | -936.3% | 10-K |
| FY2023 | $-2.01B | -222.5% | 10-K |
| FY2022 | $-623.0M | +73.4% | 10-K |
| FY2021 | $-2.34B | +93.8% | 10-K |
| FY2020 | $-37.56B | -6401.5% | 10-K |
| FY2019 | $596.0M | +159.2% | 10-K |
| FY2018 | $-1.01B | -267.2% | 10-K |
| FY2017 | $-274.0M | +95.5% | 10-K |
| FY2016 | $-6.07B | +53.0% | 10-K |
| FY2015 | $-12.94B | -1297.0% | 10-K |
| FY2014 | $-926.0M | -205.3% | 10-K |
| FY2013 | $879.0M | +136.4% | 10-K |
| FY2012 | $-2.42B | -537.3% | 10-K |
| FY2011 | $553.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →